Vivos Therapeutics’ stock soars as sleep apnea device gets regulatory clearance
November 29, 2023 at 11:09 AM EST
Vivos Therapeutics jumped more than 270% after the FDA cleared the company's devices for severe sleep apnea.
Photography by Christophe Tomatis